# Evaluation of BH4 Responsiveness in Our PKU Patients

> **NCT07255599** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Sohag University** · enrollment: 20 (estimated)

## Conditions studied

- Phenylketonuria (PKU)

## Interventions

- **DRUG:** Sapropterin Dihydrochloride (BH4, tetrahydrobiopterin)

## Key facts

- **NCT ID:** NCT07255599
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07255599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07255599, "Evaluation of BH4 Responsiveness in Our PKU Patients". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT07255599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*